Royal Bank of Canada’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

Royal Bank of Canada’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-2,695	Closed	-$125K	–	7916
2023 Q2	$125K	Buy	2,695 +703	+35%	+$24.3K	﹤0.01%	5155
2023 Q1	$57K	Sell	1,992 -2,580	-56%	-$76.4K	﹤0.01%	5558
2022 Q4	$143K	Buy	4,572 +4,226	+1,221%	+$138K	﹤0.01%	5176
2022 Q3	$7K	Buy	346 +186	+116%	+$3.39K	﹤0.01%	6632
2022 Q2	$2K	Sell	160 -696	-81%	-$12K	﹤0.01%	7034
2022 Q1	$16K	Sell	856 -1,992	-70%	-$35.6K	﹤0.01%	6738
2021 Q4	$72K	Buy	+2,848	New	+$83.5K	﹤0.01%	6166

Royal Bank of Canada's DICE Position: Q3 2023 in Review

Royal Bank of Canada sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 2,695 shares — an estimated $125K sold.

Royal Bank of Canada first reported a position in DICE in Q4 2021 and held it in 7 quarters. The position peaked at $143K in Q4 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

Royal Bank of Canada reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
Royal Bank of Canada sold 2,695 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $125K.
Royal Bank of Canada first reported a position in DICE Therapeutics, Inc. Common Stock in Q4 2021 and held it in 7 quarters.
Royal Bank of Canada's DICE Therapeutics, Inc. Common Stock position peaked at $143K in Q4 2022.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on Royal Bank of Canada's 13F filing for Q3 2023, filed 14 Nov 2023.